BIO-RAD LABORATORIES, INC.
BIO-BNYSE
$309.37
↑ +3.6%Jul 13 close · end-of-day
Price
1Y↑ +25.2%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$8.3B
Enterprise Value
$7.6B
P/E
51.5
P/S
3.2
P/B
1.2
EV/EBITDA
—
PEG
—
FCF Yield
4.3%
Dividend Yield
—
Revenue (TTM)
$2.6B
Net Income (TTM)
$168.8M
Free Cash Flow (TTM)
$357.2M
Gross Margin
51.9%
Operating Margin
2.2%
Net Margin
6.5%
ROE
2.5%
ROIC
0.7%
Debt / Equity
0.1
Net Cash
$761.8M
Return 1Y
+20.0%
Company profile
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, sells, and markets a range of reagents, apparatus, and laboratory instruments. The clinical Diagnostics segment offers test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories.
- CEO
- Norman D. Schwartz
- Sector
- Manufacturing
- Industry
- Measuring And Control Equipment
- Employees
- 8,200
- Headquarters
- California
- Website
- bio-rad.com
Management & directors
- Engelhardt Eva AnetteEVP, President, CDG
- Enloe Courtney CEVP, General Counsel & Sec
- Lakkaraju Roop KalyanEVP, Chief Financial Officer
- Barry JamesEVP, President, LSG
- Divincenzo Jonathan P.President & COO
- Evran SedatEVP, Global Supply Chain
- Corey ColleenEVP, Global Human Resources
- Schwartz Norman DChairman & CEO
Roles derived from SEC Form 4 filings.
Earnings
BIO-B Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$592.1M↑ +1.1%
Diluted EPS-$19.55↓ -953.7%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $2.5B | $2.9B | $2.8B | $2.7B | $2.6B | $2.6B |
| Gross profit | $1.4B | $1.6B | $1.6B | $1.4B | $1.4B | $1.3B |
| Operating income | $421.3M | $500.3M | $482.6M | $337.8M | $269.0M | $47.2M |
| Net income | $3.8B | $4.3B | -$3.6B | -$637.3M | -$1.8B | $759.9M |
| Diluted EPS | $126.47 | $140.83 | -$121.79 | -$21.82 | -$65.36 | $27.85 |
| Operating cash flow | $585.0M | $669.5M | $194.4M | $374.9M | $455.2M | $532.2M |
| Free cash flow | $476.4M | $535.7M | $81.6M | $218.2M | $289.6M | $374.6M |
| Gross margin | 56.5% | 56.1% | 55.9% | 53.4% | 53.7% | 51.9% |
| Operating margin | 16.6% | 17.1% | 17.2% | 12.6% | 10.5% | 1.8% |
| Net margin | 149.8% | 145.6% | -129.5% | -23.9% | -71.9% | 29.4% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $638.5M | $649.7M | $667.5M | $585.4M | $651.6M | $653.0M | $693.2M | $592.1M |
| Gross profit | $355.1M | $355.9M | $342.0M | $306.0M | $345.3M | $343.4M | $345.2M | $309.4M |
| Operating income | $101.5M | $64.5M | $58.4M | $23.7M | $77.1M | $65.3M | -$118.9M | $34.1M |
| Net income | -$2.2B | $653.2M | -$715.8M | $64.0M | $317.8M | -$341.9M | $720.0M | -$527.1M |
| Diluted EPS | -$76.26 | $23.34 | -$25.57 | $2.29 | $11.67 | -$12.70 | $26.59 | -$19.55 |
| Operating cash flow | $97.6M | $163.6M | $124.2M | $129.9M | $116.5M | $120.9M | $164.9M | $108.1M |
| Free cash flow | $55.3M | $123.4M | $81.3M | $95.5M | $70.8M | $89.2M | $119.1M | $78.1M |
| Gross margin | 55.6% | 54.8% | 51.2% | 52.3% | 53.0% | 52.6% | 49.8% | 52.3% |
| Operating margin | 15.9% | 9.9% | 8.7% | 4.0% | 11.8% | 10.0% | -17.2% | 5.8% |
| Net margin | -339.2% | 100.5% | -107.2% | 10.9% | 48.8% | -52.4% | 103.9% | -89.0% |
Company news
Jun 22, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-11 | ENGELHARDT EVA ANETTE· EVP, President, CDG | Sale | 550 | $246.54 | $135,597.00 | filing |
| 2026-04-24 | Lakkaraju Roop Kalyan· EVP, Chief Financial Officer | Tax withholding | 420 | $287.84 | $120,892.80 | filing |
| 2026-04-24 | ENLOE COURTNEY C· EVP, General Counsel & Sec | Tax withholding | 77 | $287.84 | $22,163.68 | filing |
| 2026-04-24 | Lakkaraju Roop Kalyan· EVP, Chief Financial Officer | Option exercise | 1,078 | $0.00 | $0.00 | filing |
| 2026-04-24 | ENLOE COURTNEY C· EVP, General Counsel & Sec | Option exercise | 186 | $0.00 | $0.00 | filing |
| 2026-04-21 | EDWARDS JEFFREY L | Option exercise | 407 | $0.00 | $0.00 | filing |
| 2026-04-21 | HINCKLEY GREGORY K | Option exercise | 407 | $0.00 | $0.00 | filing |
| 2026-04-21 | PEI MELINDA LITHERLAND | Option exercise | 407 | $0.00 | $0.00 | filing |
| 2026-04-21 | PINKSTON ARNOLD A | Option exercise | 407 | $0.00 | $0.00 | filing |
| 2025-11-06 | BARRY JAMES· EVP, President, LSG | Sale | 700 | $306.18 | $214,288.51 | filing |
| 2025-10-24 | DiVincenzo Jonathan P.· President & COO | Tax withholding | 950 | $339.75 | $322,762.50 | filing |
| 2025-10-24 | DiVincenzo Jonathan P.· President & COO | Option exercise | 1,869 | $0.00 | $0.00 | filing |
| 2025-10-20 | EVRAN SEDAT· EVP, Global Supply Chain | Tax withholding | 335 | $321.90 | $107,836.50 | filing |
| 2025-10-20 | EVRAN SEDAT· EVP, Global Supply Chain | Option exercise | 1,044 | $0.00 | $0.00 | filing |
| 2025-09-06 | SCHWARTZ NORMAN D· Chairman & CEO | Tax withholding | 1,528 | $295.43 | $451,417.04 | filing |
| 2025-09-06 | Lakkaraju Roop Kalyan· EVP, Chief Financial Officer | Tax withholding | 550 | $295.43 | $162,486.50 | filing |
| 2025-09-06 | ENGELHARDT EVA ANETTE· EVP, President, CDG | Tax withholding | 413 | $295.43 | $122,012.59 | filing |
| 2025-09-06 | BARRY JAMES· EVP, President, LSG | Tax withholding | 378 | $295.43 | $111,672.54 | filing |
| 2025-09-06 | EVRAN SEDAT· EVP, Global Supply Chain | Tax withholding | 277 | $295.43 | $81,834.11 | filing |
| 2025-09-06 | ENLOE COURTNEY C· EVP, General Counsel & Sec | Tax withholding | 275 | $295.43 | $81,243.25 | filing |
| 2025-09-06 | COREY COLLEEN· EVP, Global Human Resources | Tax withholding | 209 | $295.43 | $61,744.87 | filing |
| 2025-09-06 | Allison Schwartz | Tax withholding | 33 | $295.43 | $9,749.19 | filing |
| 2025-09-06 | SCHWARTZ NORMAN D· Chairman & CEO | Option exercise | 3,455 | $0.00 | $0.00 | filing |
| 2025-09-06 | EVRAN SEDAT· EVP, Global Supply Chain | Option exercise | 864 | $0.00 | $0.00 | filing |
| 2025-09-06 | Lakkaraju Roop Kalyan· EVP, Chief Financial Officer | Option exercise | 1,535 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.